Regatta Capital Group LLC Has $457,000 Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Regatta Capital Group LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.0% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 782 shares of the healthcare conglomerate’s stock after selling 50 shares during the period. Regatta Capital Group LLC’s holdings in UnitedHealth Group were worth $457,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of UNH. Swedbank AB acquired a new position in UnitedHealth Group during the 1st quarter worth approximately $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in shares of UnitedHealth Group by 107.8% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock worth $1,141,113,000 after purchasing an additional 1,196,758 shares in the last quarter. Lone Pine Capital LLC acquired a new position in UnitedHealth Group during the second quarter worth $480,903,000. Dimensional Fund Advisors LP grew its holdings in shares of UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after buying an additional 880,183 shares during the last quarter. Finally, Baillie Gifford & Co. raised its holdings in shares of UnitedHealth Group by 1,125.4% in the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock worth $455,281,000 after acquiring an additional 821,050 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Truist Financial increased their price objective on UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Royal Bank of Canada upped their target price on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Robert W. Baird boosted their target price on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Finally, StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, September 25th. Two equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $617.37.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Trading Down 8.4 %

NYSE:UNH opened at $554.45 on Wednesday. The stock’s fifty day moving average price is $584.11 and its two-hundred day moving average price is $532.57. The company has a market cap of $510.31 billion, a P/E ratio of 33.89, a P/E/G ratio of 1.66 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same period last year, the business earned $6.14 earnings per share. UnitedHealth Group’s revenue was up 6.4% compared to the same quarter last year. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.